Oxford Biomedica Solutions
David Hamilton is an experienced professional in the field of warehousing and materials management, currently serving as the Vice President of cGMP Warehousing at Tobin Scientific since September 2023. Prior to this role, David held the position of Senior Director of cGMP Warehousing and Lab Asset Management at Oxford Biomedica Solutions from January 2019 until September 2023, after serving as Director and Associate Director of Warehouse Operations at the same company. David's career also includes a role as Warehouse Manager at Homology Medicines, Inc., and Materials Management Warehouse Supervisor at Shire Pharmaceuticals. David began working at Shire in August 2009 as a Senior Driver and gained valuable experience as a Senior Materials Coordinator II at Pfizer from June 2002 to August 2009.
Oxford Biomedica Solutions
Oxford Biomedica Solutions, LLC is the high-performing, full scope Adeno-Associated Virus (AAV) vector Manufacturing and Innovation joint venture of Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Group”), and Homology Medicines, Inc. (Nasdaq: FIXX) (“Homology”). We offer global pharmaceutical and biotechnology clients innovative manufacturing expertise in AAV and lentiviral-based cell and gene therapies. Oxford Biomedica Solutions LLC provides access to Homology’s innovative and proven end-to-end AAV manufacturing capabilities, and customers also benefit from technical synergies brought in by the Group’s know-how in lentiviral vector manufacturing. This collaborative and complementary vector-based approach has the potential to accelerate our collective mission to improve patients’ lives worldwide.